Buy ImmunoCellular Therapeutics Stock | IMUC Stock Price & Latest News | Public

IMUC

ImmunoCellular Therapeutics

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About IMUC

ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associ...Read more

Community

People who own or watch this stock

Buy any stock with any amount of money.

Download the App
Download the app

Stats

Market Cap$1,17M
Volume
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$0.05
1 Year Low$0.02
Open
High
Low

Buy any stock with any amount of money.

Download the App
Download the app